Login
← Go Back
Glenmark Life Sciences
GLS · Pharma > Pharmaceuticals & Drugs · Chairman: Glenn Saldanha · MD: Yasir Rawjee · Listing date: Aug. 7, 2021 · Employees: 1537 · Mumbai · http://www.glenmarklifesciences.com
Stock Price vs Company Growth
1d
1.4%
1w
1.9%
1m
4.0%
3m
4.6%
6m
33.8%
1y
70.2%
all
8.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 829 1.4%
666
904
Company Overview
Sales
2,283 Cr
Growth: 9.8%
Profit after Tax
471 Cr
Growth: -9.3%
Mid Cap
10,163 Cr
P/E: 21.6x
Industry P/E: 35.0x
Fundamentals
Sales (Cr) ₹ 2,283
Growth 9.8%
EBITDA 29.5%
P/S 4.5x
Dividend 3.4%
P/E 21.6x
Book Value ₹ 190
PEG Ratio 2.2x
ROE 19.8%
P/B 4.4x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is in the business of making high-quality drugs by unlocking the possibilities of science.Awards, accreditations and recognitions2015: Ankleshwar plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Dahej plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Ankleshwar plant received BS OHSAS 18001:2017 certifying the management system of the manufacturing facility.
Belongs to (10 Indices) view more
Investors (5)
nirma
polar.ca...
santhosh...
Followers (1)
atharav